59,842 Shares in Sotera Health Company $SHC Acquired by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC acquired a new stake in Sotera Health Company (NASDAQ:SHC) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 59,842 shares of the company’s stock, valued at approximately $1,125,000.

Several other large investors have also recently added to or reduced their stakes in the company. Empowered Funds LLC grew its stake in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after acquiring an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Sotera Health by 14.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after purchasing an additional 43,471 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares during the period. Creative Planning grew its position in shares of Sotera Health by 15.3% during the 2nd quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after purchasing an additional 2,673 shares in the last quarter. Finally, Legal & General Group Plc grew its position in shares of Sotera Health by 3.9% during the 2nd quarter. Legal & General Group Plc now owns 254,274 shares of the company’s stock worth $2,828,000 after purchasing an additional 9,462 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the sale, the director directly owned 12,735,301 shares in the company, valued at $194,468,046.27. This trade represents a 43.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 47.55% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

SHC has been the topic of a number of analyst reports. Wells Fargo & Company downgraded Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $17.00 to $24.00 in a report on Friday, January 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Finally, Royal Bank Of Canada assumed coverage on shares of Sotera Health in a research report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 target price for the company. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.43.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $14.96 on Monday. The company’s 50 day moving average price is $15.85 and its two-hundred day moving average price is $16.53. The firm has a market capitalization of $4.25 billion, a P/E ratio of 55.41 and a beta of 1.88. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.Sotera Health’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the business posted $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.